Progress and prospect of epidermal growth factor receptor tyrosine kinase inhibitor in treatment of non-small cell lung cancer
Clinical and pathological features of IDH1-mutant glioblastoma: analysis of 10 cases
Predictive value of clinical parameters in responses to epidermal growth factor-tyrosine kinase inhibitors as first-line therapy for stage Ⅳ non-small cell lung cancer
264例肺腺癌患者EGFR基因突变及TKI类药物临床疗效分析
Related Author
张庆玲
王亚丽
Hanshui JIANG
Guoming WU
Ying ZENG
Peng ZHONG
Xiangfeng ZHU
Li LIN
Related Institution
Department of Respiratory and Critical Care Medicine, Shulan (Hangzhou) Hospital
Department of Pathology, Second Affiliated Hospital, Army Medical University (Third Military Medical University)
Department of Pathology, Daping Hospital, Army Medical University (Third Military Medical University)
Cancer Institute, Second Affiliated Hospital, Army Medical University (Third Military Medical University)